Prosperity Consulting Group LLC Has $3.31 Million Stock Holdings in UnitedHealth Group Incorporated $UNH

Prosperity Consulting Group LLC trimmed its position in UnitedHealth Group Incorporated (NYSE:UNH) by 10.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 10,609 shares of the healthcare conglomerate’s stock after selling 1,216 shares during the quarter. Prosperity Consulting Group LLC’s holdings in UnitedHealth Group were worth $3,310,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Brighton Jones LLC increased its position in UnitedHealth Group by 176.2% in the fourth quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC grew its position in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after buying an additional 2,324 shares during the period. Cloud Capital Management LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth about $53,000. Financiere des Professionnels Fonds d investissement inc. grew its position in shares of UnitedHealth Group by 10.6% during the 1st quarter. Financiere des Professionnels Fonds d investissement inc. now owns 811 shares of the healthcare conglomerate’s stock worth $425,000 after buying an additional 78 shares during the period. Finally, Envestnet Asset Management Inc. grew its position in shares of UnitedHealth Group by 4.7% during the 1st quarter. Envestnet Asset Management Inc. now owns 2,239,866 shares of the healthcare conglomerate’s stock worth $1,173,130,000 after buying an additional 99,979 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research firms have recently issued reports on UNH. Wells Fargo & Company boosted their target price on UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Royal Bank Of Canada lifted their price objective on UnitedHealth Group from $286.00 to $408.00 and gave the company an “outperform” rating in a report on Wednesday, October 29th. Deutsche Bank Aktiengesellschaft cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price objective on the stock. in a report on Wednesday, October 29th. TD Cowen lifted their price objective on UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a report on Thursday, October 30th. Finally, Zacks Research upgraded UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Eighteen investment analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Trading Down 2.3%

NYSE UNH opened at $333.87 on Tuesday. The stock has a market capitalization of $302.43 billion, a price-to-earnings ratio of 17.43, a PEG ratio of 2.28 and a beta of 0.47. The stock’s 50 day moving average price is $344.08 and its two-hundred day moving average price is $324.95. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The firm had revenue of $113.16 billion for the quarter, compared to analysts’ expectations of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s quarterly revenue was up 12.2% compared to the same quarter last year. During the same quarter in the previous year, the business posted $7.15 EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s dividend payout ratio is currently 46.14%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.